Risk factors for second primary tumours in breast cancer survivors

European Journal of Cancer Prevention

Volumn 17, Issue 5, 2008, Pages 406-413

  Sánchez, Luis ^a   Lana, Alberto ^a   Hidalgo, Agustín ^a   Rodríguez, Jose María ^b   Del Valle, María Del Olivo ^a   Cueto, Antonio ^a   Folgueras, María Victoria ^b   Belyakova, Elena ^b   Comendador, Miguel Ángel ^a   López, María Luisa ^a,c  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b Central University Hospital   (Spain)

^c UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

Breast neoplasms; Casecontrol studies; Control; Neoplasm; Prevention; Risk factors; Second primary

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; MITOXANTRONE;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CIGARETTE SMOKING; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HEALTH EDUCATION; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METASTASIS; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; SECOND CANCER; SPAIN; BREAST TUMOR; CASE CONTROL STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; FOLLOW UP; MORTALITY; OVARY TUMOR; PATHOLOGY; RISK FACTOR; SKIN TUMOR; STATISTICS; SURVIVAL; SURVIVOR;

BREAST NEOPLASMS; CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASMS, SECOND PRIMARY; OVARIAN NEOPLASMS; RISK FACTORS; SKIN NEOPLASMS; SURVIVAL ANALYSIS; SURVIVORS;

EID: 56149108082     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3282f75ee5     Document Type: Article

References (53)

1. Boekhout AH, Beijnen JH, Schellens JH (2006). Symptoms and treatment in cancer therapy-induced early menopause. Oncologist 11:641-654.
2. Brunetti D, Tamaro P, Fanin R, Cavallieri F, Stanta G (2005). Family history of cancer and risk of second malignancies in young cancer patients in Trieste, Italy. Int J Cancer 115:814-821
3. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638.
4. Chaplain G, Milan C, Sgro C, Carli PM, Bonithon-Kopp C (2000). Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study. J Clin Oncol 18:2836-2842.
5. Demandante CG, Troyer DA, Miles TP (2003). Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol 26:79-83.
6. Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM (2005). Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 23:5814-5830.
7. Dong C, Hemminki K (2001a). Second primary neoplasms in 633 964 cancer patients in Sweden, 1958-1996. Int J Cancer 93:155-161.
8. Dong C, Hemminki K (2001b). Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers. Int J Cancer 92:883-887.
9. Folgueras V, Astudillo A, Zaplana J (2007). Asturias central university hospital tumour registry: year 2002 summary. Oviedo: Asturias Central University Hospital, Principality of Asturias University Oncology Institute.
10. Fowble B, Hanlon A, Freedman G, Nicolaou N, Anderson P (2001). Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys 51:679-690.
11. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM (2000). International classification of diseases for oncology (ICD-O). Geneva: WorldHealth Organization.
12. Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, et al. (2002). Second non-breast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 52:406-414.
13. Garcia LA, Lagergren J, Lindblad M (2006). Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut 55:1538-1544.
14. Gierach GL, Modugno F, Ness RB (2005). Relations of gestational length and timing and type of incomplete pregnancy to ovarian cancer risk. Am J Epidemiol 161:452-461.
15. Hachisuga T, Saito T, Kigawa J, Ohwada M, Yamazawa K, Yasue A, et al. (2004). Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers. Gynecol Oncol 95: 139-144.
16. Hemminki K, Aaltonen L, Li X (2003). Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma. Cancer 97:2432-2439.
17. Hemminki K, Rawal R, Chen B, Bermejo JL (2004). Genetic epidemiology of cancer: from families to heritable genes. Int J Cancer 111:944-950.
18. Hotes JL, Ellison LF, Howe HL, Friesen I, Kohler B (2004). Variation in breast cancer counts using SEER and IARC multiple primary coding rules. Cancer Causes Control 15:185-191.
19. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S (2006). Diabetes mellitus and the risk of cancer: results from a large-scale population-basedcohort study in Japan. Arch Intern Med 166:1871-1877.
20. Kmet LM, Cook LS, Weiss NS, Schwartz SM, White E (2003). Risk factors for colorectal cancer following breast cancer. Breast Cancer Res Treat 79: 143-147.
21. Levi F, Te VC, Randimbison L, La Vecchia C (2003). Cancer risk in women with previous breast cancer. Ann Oncol 14:71-73.
22. Levi F, Randimbison L, Te VC, La Vecchia C (2006). Cancer risk after radiotherapy for breast cancer. Br J Cancer 95:390-392.
23. Lindgren AM, Nissinen AM, Tuomilehto JO, Pukkala E (2005). Cancer pattern among hypertensive patients in North Karelia, Finland. J Hum Hypertens 19: 373-379.
24. López ML, Iglesias JM, del Valle MO, Comas A, Fernández JM, de Vries H, et al. (2007). Impact of a primary care intervention on smoking, drinking, diet, weight, sun exposure, and work risk in families with cancer experience. Cancer Causes Control 18:525-535.
25. Matesich SM, Shapiro CL (2003). Second cancers after breast cancer treatment. Semin Oncol 30:740-748.
26. Mayne ST, Cartmel B (2006). Chemoprevention of second cancers. Cancer Epidemiol Biomarkers Prev 15:2033-2037.
27. Mellemkjaer L, Friis S, Olsen JH, Scelo G, Hemminki K, Tracey E, et al. (2006). Risk of second cancer among women with breast cancer. Int J Cancer 118: 2285-2292.
28. Nkondjock A, Robidoux A, Paredes Y, Narod SA, Ghadirian P (2006). Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians. Breast Cancer Res Treat 98:285-294.
29. Parkin DM (2006). The evolution of the population-based cancer registry. Nat Rev Cancer 6:603-612.
30. Parkin DM, Shanmugaratnam K, Sobin L, Ferlay J, Whelan SL (1998). Histological groups for comparative studies. IARC Technical Report no. 31. Lyon: IARC Press.
31. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (2002). Cancer incidence in five continents. Vol. VIII. IARC Scientific Publication no. 155. Lyon: IARC Press.
32. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
33. Raymond JS, Hogue CJ (2006). Multiple primary tumours in women following breast cancer, 1973-2000. Br J Cancer 94:1745-1750.
34. Rosenblatt KA, Gao DL, Ray RM, Rowland MR, Nelson ZC, Wernli KJ, et al. (2006). Induced abortions and the risk of all cancers combined and site-specific cancers in Shanghai. Cancer Causes Control 17:1275-1280.
35. Roychoudhuri R, Evans H, Robinson D, Moller H (2004). Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer 91: 868-872.
36. Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Le MG (2000). Increased risk of second cancers following breast cancer: role of the initial treatment. Breast Cancer Res Treat 61:183-195.
37. Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Grimaud E, Labbe M, et al. (2002). Radiation dose, chemotherapy and risk of lung cancer after breast cancer treatment. Breast Cancer Res Treat 75:15-24.
38. Rubino C, de Vathaire F, Shamsaldin A, Labbe M, Le MG (2003). Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer 89:840-846.
39. Rubino C, Shamsaldin A, Le MG, Labbe M, Guinebretiere JM, Chavaudra J, de Vathaire F (2005). Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment. Breast Cancer Res Treat 89:277-288.
40. Samet J, Yoon SY (2001). Women and the tobacco epidemic: challenges for the 21st century. WHO Monograph WHO/NMH/TFI/01.1. Geneva: World Health Organization.
41. Saso R, Kulkarni S, Mitchell P, Treleaven J, Swansbury GJ, Mehta J, et al. (2000). Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma. Br J Cancer 83:91-94.
42. Shih HA, Nathanson KL, Seal S, Collins N, Stratton MR, Rebbeck TR, Weber BL(2000). BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers. Clin Cancer Res 6:4259-4264.
43. Soerjomataram I, Louwman WJ, de Vries E, Lemmens VE, Klokman WJ, Coebergh JW (2005). Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001. Breast Cancer Res Treat 93: 91-95.
44. Travis LB (2002). Therapy-associated solid tumors. Acta Oncol 41:323-333.
45. Travis LB (2006). The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev 15:2020-2026.
46. Trentham-Dietz A, Newcomb PA, Nichols HB, Hampton JM (2006). Breast cancer risk factors and second primary malignancies among women with breast cancer. Breast Cancer Res Treat 105:195-207.
47. Vogel VG (2006). Identifying and screening patients at risk of second cancers. Cancer Epidemiol Biomarkers Prev 15:2027-2032.
48. Walshe JM, Denduluri N, Swain SM (2006). Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 24: 5769-5779.
49. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, et al. (1997). Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89:1360-1365.
50. Wolk A, Gridley G, Svensson M, Nyren O, McLaughlin JK, Fraumeni JF, Adam HO (2001). A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12:13-21.
51. Working Group Report (2005). International rules for multiple primary cancers (ICD-0 third edition). Eur J Cancer Prev 14:307-308.
52. Wu AH, Tseng CC, Bernstein L (2003). Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer 98: 940-948.
53. Yu GP, Schantz SP, Neugut AI, Zhang ZF (2006). Incidences and trends of second cancers in female breast cancer patients: a fixed inception cohort-based analysis (United States). Cancer Causes Control 17:411-420.